Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy

Circulation

Volumn 110, Issue 11 SUPPL., 2004, Pages

  Perin, Emerson C ^a,d   Dohmann, Hans F R ^b,d   Borojevic, Radovan ^c   Silva, Suzana A ^b   Sousa, Andre L S ^b   Silva, Guilherme V ^a   Mesquita, Claudio T ^b   Belém, Luciano ^b   Vaughn, William K ^a   Rangel, Fernando O D ^b   Assad, Joao A R ^b   Carvalho, Antonio C ^c   Branco, Rodrigo V C ^a   Rossi, Maria I D ^c   Dohmann, Hans J F ^b   Willerson, James T ^a  

^a ST LUKE S EPISCOPAL HOSPITAL   (United States)

^b HOSPITAL PRÓ CARDÍACO   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d NONE   (Brazil)

Author keywords

Cells; Gene therapy; Heart failure; Ischemia; Revascularization

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITRATE;

ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; B LYMPHOCYTE; CARDIOMYOPATHY; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DOPPLER ECHOGRAPHY; EXERCISE; EXERCISE TEST; FEMALE; FOLLOW UP; HEART MUSCLE ISCHEMIA; HEMATOPOIETIC STEM CELL; HOLTER MONITORING; HUMAN; LABORATORY TEST; MALE; MONOCYTE; MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; B-LYMPHOCYTES; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL LINEAGE; ECHOCARDIOGRAPHY, DOPPLER; ELECTROCARDIOGRAPHY, AMBULATORY; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INJECTIONS; MALE; MIDDLE AGED; MONOCYTES; MYOCARDIAL ISCHEMIA; OXYGEN CONSUMPTION; PROSPECTIVE STUDIES; RECURRENCE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 4644287958     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000138398.77550.62     Document Type: Article

References (27)

1. American Heart Association. 2001 Heart and Stroke Statistical Update. Dallas, Tex: American Heart Association; 2000.
2. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction: experimental observations and clinical implications. Circulation. 1990;81:1161-1172.
3. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410:701-705.
4. Kocher AA, Schuster MD, Szabolcs MJ, et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med. 2001;7:430-436.
5. Menasche P, Hagege AA, Vilquin JT, et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol. 2003;41:1078-1083.
6. Kawamoto A, Gwon HC, Iwaguro H, et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation. 2001;103:634-637.
7. Fuchs S, Baffour R, Zhou YF, et al. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J Am Coll Cardiol. 2001;37:1726-1732.
8. Tomita S, Mickle D, Weisel R, et al. Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation. J Thorac Cardiovasc Surg. 2002;123: 1132-1140.
9. Tse HF, Kwong YL, Chan JK, et al. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet. 2003;361:47-49.
10. Stamm C, Westphal B, Kleine HD, et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet. 2003;361: 45-46.
11. Strauer BE, Brehm M, Zeus T, et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation. 2002;106:1913-1918.
12. Assmus B, Schachinger V, Teupe C, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation. 2002;106:3009-3017.
13. Perin EC, Dohmann HF, Borojevic R, et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation. 2003;107:2294-2302.
14. Gibbons RJ, Balady GJ, Bricker TJ, et al. ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). J Am Coll Cardiol. 2002;40:1531-1540.
15. Coutinho LH, Gilleece MH, de Wynter EA, et al. Clonal and long-term cultures using human bone marrow. In: Testa NG, Molineux G, eds. Haemopoiesis: A Practical Approach. New York, NY: Oxford University Press; 1993:84-85.
16. Castro-Malaspina H, Gay RE, Resnick G, et al. Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood. 1980;56:289-301.
17. Perin EC, Silva GV, Sarmento-Leite R, et al. Assessing myocardial viability and infarct transmurality with left ventricular electromechanical mapping in patients with stable coronary artery disease: validation by delayed-enhancement magnetic resonance imaging. Circulation. 2002; 106:957-961.
18. American College of Sport Medicine. Guidelines for Exercise Testing and Exercise Prescription. 6th ed. Philadelphia, Penn: Lippincott Williams & Wilkins; 2000.
19. Asahara T, Masuda H, Takahashi T, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res. 1999;85: 221-228.
20. Hristov M, Erl W, Weber PC. Endothelial progenitor cells: mobilization, differentiation, and homing. Arterioscler Thromb Vasc Biol. 2003;23: 1185-1189.
21. Badorff C, Brandes RP, Popp R. Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation. 2003;107:1024-1032.
22. Perin E, Geng Y, Willerson JT. Adult stem cell, therapy in perspective. Circulation. 2003;107:935-938.
23. Rehman J, Li J, Orschell CM, March KL. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation. 2003;107:1164-1169.
24. Clerico A, Emdin M. Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review. Clin Chem. 2004; 50:33-50.
25. 2 determination in chronic heart failure: is it still of value? Eur Heart J. 1994;15:495-502.
26. Fuchs S, Satler L, Kornowski R. Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease: a feasibility study. J Am Coll Cardiol. 2003;41:1721-1724.
27. Dimmeler S, Vasa-Nicotera M. Aging of progenitor cells: limitation for regenerative capacity? J Am Coll Cardiol. 2003;42:2081-2082.